trending Market Intelligence /marketintelligence/en/news-insights/trending/5mhrtXaWbic51W9KyDpd7w2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Carmike investor threatens litigation over AMC deal maneuvering

Podcast

Episode 1: Origins of 451 Research - Part 1

Podcast

Episode 3: Transformation of Customer Experience in 2020

Podcast

Episode 2: Origins of 451 Research - Part 2

Blog

Culture of success: 451 Research survey highlights the keys to strong data and analytics initiatives


Carmike investor threatens litigation over AMC deal maneuvering

Carmike CinemasInc. investor Mittleman Brothers, which owns about 9.6% of the company'sstock, is threatening legal action if Carmike postpones the record date establishingeligibility for shareholders to vote on the company's planned sale to AMCEntertainment Holdings Inc.

The investor expressed alarm at rumors that the record date wasbeing delayed in an attemptby AMC to win over shareholders to vote in its favor.

Further, Mittleman Brothers argued that Carmike should be soldfor no less than $37.50 per share, higher than either the $30 per share offer thatAMC has officially proposed or the $33 per share that is reported to be considering. The investor pointed to AMC'sannounced of European theater chainOdeon & UCI Cinemas Group as evidence that its offer for Carmike was inadequate,saying AMC's Carmike offer represents an EV/EBITDA multiple of 7.9x post synergiesadjusted EBITDA versus a multiple of 9.0x for Odeon & UCI.

Currently, Carmike shareholders of record as of May 18 are scheduledto vote July 25 on whether to accept AMC's offer.